메뉴 건너뛰기




Volumn 18, Issue SUPPL2, 2014, Pages 8-12

Clinical Effects of the New Phosphorus Binder, Bixalomer in Hemodialysis Patients Switched From Sevelamer Hydrochloride

Author keywords

Bixalomer; Gastrointestinal symptom rating scale; Gastrointestinal symptoms; Serum phosphorus concentration; Sevelamer hydrochloride

Indexed keywords

BIXALOMER; CALCIUM; PARATHYROID HORMONE; PHOSPHORUS; SEVELAMER; CHELATING AGENT; POLYAMINE;

EID: 84903468014     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/1744-9987.12228     Document Type: Article
Times cited : (3)

References (12)
  • 1
    • 33645757920 scopus 로고    scopus 로고
    • Kidney Disease: Improving Global Outcomes (KDIGO). Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)
    • Moe S, Drüeke T, Cunningham J etal. Kidney Disease: Improving Global Outcomes (KDIGO). Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2006;69:1945-1953.
    • (2006) Kidney Int , vol.69 , pp. 1945-1953
    • Moe, S.1    Drüeke, T.2    Cunningham, J.3
  • 2
    • 84876423710 scopus 로고    scopus 로고
    • CKD-MBD Guideline Working Group; Japanese Society for Dialysis Therapy. Clinical practice guideline for the management of chronic kidney disease-mineral and bone disorder
    • Fukagawa M, Yokoyama K, Koiwa F etal. CKD-MBD Guideline Working Group; Japanese Society for Dialysis Therapy. Clinical practice guideline for the management of chronic kidney disease-mineral and bone disorder. Ther Apher Dial 2013;17:247-288.
    • (2013) Ther Apher Dial , vol.17 , pp. 247-288
    • Fukagawa, M.1    Yokoyama, K.2    Koiwa, F.3
  • 3
    • 0342588049 scopus 로고    scopus 로고
    • Arterial stiffening and vascular calcifications in end-stage renal disease
    • Guerin AP, London GM, Marchais SJ etal. Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrol Dial Transplant 2000;15:1014-1021.
    • (2000) Nephrol Dial Transplant , vol.15 , pp. 1014-1021
    • Guerin, A.P.1    London, G.M.2    Marchais, S.J.3
  • 4
    • 0035725506 scopus 로고    scopus 로고
    • Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease
    • Blacher J, Guerin AP, Pannier B etal. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 2001;38:938-942.
    • (2001) Hypertension , vol.38 , pp. 938-942
    • Blacher, J.1    Guerin, A.P.2    Pannier, B.3
  • 5
    • 0032962093 scopus 로고    scopus 로고
    • Effect of histamine H2-receptor antagonist on the phosphorus-binding abilities of calcium carbonate and calcium lactate in hemodialysis patients
    • Takahashi N, Shoji T, Matsubara K etal. Effect of histamine H2-receptor antagonist on the phosphorus-binding abilities of calcium carbonate and calcium lactate in hemodialysis patients. J Am Soc Nephrol 1999;10:1090-1094.
    • (1999) J Am Soc Nephrol , vol.10 , pp. 1090-1094
    • Takahashi, N.1    Shoji, T.2    Matsubara, K.3
  • 6
    • 0036310682 scopus 로고    scopus 로고
    • Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients
    • Treat to Goal Working Group
    • Chertow GM, Burke SK, Raggi P, Treat to Goal Working Group. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 2002;62:245-252.
    • (2002) Kidney Int , vol.62 , pp. 245-252
    • Chertow, G.M.1    Burke, S.K.2    Raggi, P.3
  • 7
    • 31644446801 scopus 로고    scopus 로고
    • Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis
    • Block GA, Spiegel DM, Ehrlich J etal. Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis. Kidney Int 2005;68:1815-1824.
    • (2005) Kidney Int , vol.68 , pp. 1815-1824
    • Block, G.A.1    Spiegel, D.M.2    Ehrlich, J.3
  • 8
    • 29144468253 scopus 로고    scopus 로고
    • Efficacy of combined sevelamer and calcium carbonate therapy for hyperphosphatemia in Japanese hemodialysis patients
    • Iwasaki Y, Takami H, Tani M etal. Efficacy of combined sevelamer and calcium carbonate therapy for hyperphosphatemia in Japanese hemodialysis patients. Ther Apher Dial 2005;9:347-351.
    • (2005) Ther Apher Dial , vol.9 , pp. 347-351
    • Iwasaki, Y.1    Takami, H.2    Tani, M.3
  • 9
    • 29144448055 scopus 로고    scopus 로고
    • Prospective randomized multicenter trial of sevelamer hydrochloride and calcium carbonate for the treatment of hyperphosphatemia in hemodialysis patients in Japan
    • ROD 21 Clinical Research Group
    • Koiwa E, Onoda N, Kato H etal. ROD 21 Clinical Research Group. Prospective randomized multicenter trial of sevelamer hydrochloride and calcium carbonate for the treatment of hyperphosphatemia in hemodialysis patients in Japan. Ther Apher Dial 2005;9:340-346.
    • (2005) Ther Apher Dial , vol.9 , pp. 340-346
    • Koiwa, E.1    Onoda, N.2    Kato, H.3
  • 10
    • 84898027950 scopus 로고    scopus 로고
    • Randomized controlled trial of bixalomer versus sevelamer hydrochloride in hemodialysis patients with hyperphosphatemia
    • the Bixalomer Study Group
    • Akizawa T, Origasa H, Kameoka C, Kaneko Y, Kawasaki S, the Bixalomer Study Group. Randomized controlled trial of bixalomer versus sevelamer hydrochloride in hemodialysis patients with hyperphosphatemia. Ther Apher Dial 2014;18:122-131.
    • (2014) Ther Apher Dial , vol.18 , pp. 122-131
    • Akizawa, T.1    Origasa, H.2    Kameoka, C.3    Kaneko, Y.4    Kawasaki, S.5
  • 11
    • 0028868486 scopus 로고
    • Well-being and gastrointestinal symptoms among patients referred to endoscopy owing to suspected duodenal ulcer
    • Dimenäs E, Glise H, Hallerbäck B, Hernqvist H, Svedlund J, Wiklund I. Well-being and gastrointestinal symptoms among patients referred to endoscopy owing to suspected duodenal ulcer. Scand J Gastroenterol 1995;30:1046-1052.
    • (1995) Scand J Gastroenterol , vol.30 , pp. 1046-1052
    • Dimenäs, E.1    Glise, H.2    Hallerbäck, B.3    Hernqvist, H.4    Svedlund, J.5    Wiklund, I.6
  • 12
    • 84890136859 scopus 로고    scopus 로고
    • Long-term treatment of hyperphosphatemia with bixalomer in Japanese hemodialysis patients
    • the Bixalomer Study Group
    • Akizawa T, Kameoka C, Kaneko Y, Kawasaki S, the Bixalomer Study Group. Long-term treatment of hyperphosphatemia with bixalomer in Japanese hemodialysis patients. Ther Apher Dial 2013;17:612-619.
    • (2013) Ther Apher Dial , vol.17 , pp. 612-619
    • Akizawa, T.1    Kameoka, C.2    Kaneko, Y.3    Kawasaki, S.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.